title: Image-guided microbeam irradiation to brain tumour bearing mice using a carbon nanotube x-ray source array.
abstract: Microbeam radiation therapy (MRT) is a promising experimental and preclinical radiotherapy method for cancer treatment. Synchrotron based MRT experiments have shown that spatially fractionated microbeam radiation has the unique capability of preferentially eradicating tumour cells while sparing normal tissue in brain tumour bearing animal models. We recently demonstrated the feasibility of generating orthovoltage microbeam radiation with an adjustable microbeam width using a carbon nanotube based x-ray source array. Here we report the preliminary results from our efforts in developing an image guidance procedure for the targeted delivery of the narrow microbeams to the small tumour region in the mouse brain. Magnetic resonance imaging was used for tumour identification, and on-board x-ray radiography was used for imaging of landmarks without contrast agents. The two images were aligned using 2D rigid body image registration to determine the relative position of the tumour with respect to a landmark. The targeting accuracy and consistency were evaluated by first irradiating a group of mice inoculated with U87 human glioma brain tumours using the present protocol and then determining the locations of the microbeam radiation tracks using γ-H2AX immunofluorescence staining. The histology results showed that among 14 mice irradiated, 11 received the prescribed number of microbeams on the targeted tumour, with an average localization accuracy of 454 µm measured directly from the histology (537 µm if measured from the registered histological images). Two mice received one of the three prescribed microbeams on the tumour site. One mouse was excluded from the analysis due to tissue staining errors.
authors.affiliation: Department of Applied Physical Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
authors.forename: Lei
authors.initials: L
authors.lastname: Zhang
authors.forename: Hong
authors.initials: H
authors.lastname: Yuan
authors.forename: Laurel M
authors.initials: LM
authors.lastname: Burk
authors.forename: Christy R
authors.initials: CR
authors.lastname: Inscoe
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Hadsell
authors.forename: Pavel
authors.initials: P
authors.lastname: Chtcheprov
authors.forename: Yueh Z
authors.initials: YZ
authors.lastname: Lee
authors.forename: Jianping
authors.initials: J
authors.lastname: Lu
authors.forename: Sha
authors.initials: S
authors.lastname: Chang
authors.forename: Otto
authors.initials: O
authors.lastname: Zhou
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D045744:Cell Line, Tumor; D004867:Equipment Design; D019544:Equipment Failure Analysis; D005910:Glioma / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D006801:Humans; D051379:Mice; D037742:Nanotubes, Carbon / Q000737:chemistry*; D020266:Radiotherapy, Conformal / Q000295:instrumentation*; D061089:Radiotherapy, Image-Guided / Q000295:instrumentation* / Q000379:methods; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000295:instrumentation* / Q000379:methods; D016896:Treatment Outcome
chemical_list: D037742:Nanotubes, Carbon